Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

ML Laboratories

ML Laboratories is to acquire Quadrant Technologies, the Nottingham-based pulmonary drug delivery specialist with 35 staff, for £47m, and has also announced plans to change its name to Innovata.

ML Laboratories has sold Healthcare Education Services, the St Albans-based provider of pharmaceutical industry training services with annual turnover of £1.2m, to Bridgehead Pharmalicensing Group.

ML Laboratories is to sell its Icodextrin glucose polymer manufacturing business in Liverpool to Baxter Healthcare for £6.5m.

ML Laboratories has raised £11m in a share placing in order to fund the development of its drug delivery business.

ML Laboratories is acquiring Cobra, the gene therapy company, for an initial £8m.